Literature DB >> 12851715

A novel single-nucleotide substitution, Leu 467 Pro, in the interferon-gamma receptor 1 gene associated with allergic diseases.

Minako Aoki1, Eiko Matsui, Hideo Kaneko, Ryosuke Inoue, Toshiyuki Fukao, Mizuho Watanabe, Takahide Teramoto, Zenichiro Kato, Kiyotaka Suzuki, Yasuyuki Suzuki, Kimiko Kasahara, Naomi Kondo.   

Abstract

We identified a novel heterozygous single-nucleotide substitution 1400 T right curved arrow C (Leu 467 Pro) in the seventh exon of the interferon-gamma receptor 1 (IFNGR1) gene. This substitution was detected in 6 of the 89 allergic patients but not in the 72 non-allergic subjects. There was a difference in the L467P frequency between the allergic patients and the non-allergic subjects (Fisher's exact test: p=0.033). The 6 patients with L467P have allergic diseases such as bronchial asthma and/or allergic rhinitis. Furthermore, a familial analysis for L467P revealed a linkage between allergic diseases and L467P. Serum IgE levels of the patients with L467P were higher than those of the non-allergic subjects (p=0.001). Our previous studies have been shown that interferon-gamma (IFN-gamma) production by PBMCs in the allergic patients was lower than that in the non-allergic subjects. In this study, although IFN-gamma production in the allergic patients with L467P was equivalent to that in the non-allergic subjects, their serum IgE levels were high and they had allergic diseases. Our results suggest that some allergic patients have IFNGR dysfunction, and that L467P in the IFNGR1 gene is one of candidate susceptibility genes for allergic diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12851715

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  7 in total

1.  Missense splice variant (g.20746A>G, p.Ile183Val) of interferon gamma receptor 1 (IFNGR1) coincidental with mycobacterial osteomyelitis - a screen of osteoarticular lesions.

Authors:  Agnieszka Bińczak-Kuleta; Aleksander Szwed; Mark R Walter; Maciej Kołban; Andrzej Ciechanowicz; Jeremy S C Clark
Journal:  Bosn J Basic Med Sci       Date:  2016-06-29       Impact factor: 3.363

2.  Relationship between the benefits of suplatast tosilate, a Th2 cytokine inhibitor, and gene polymorphisms in children with bronchial asthma.

Authors:  Eiko Matsui; Shinji Shinoda; Osamu Fukutomi; Hideo Kaneko; Toshiyuki Fukao; Naomi Kondo
Journal:  Exp Ther Med       Date:  2010-09-15       Impact factor: 2.447

3.  Pharmacogenetics of asthma in children.

Authors:  Naomi Kondo; Eiko Matsui; Akane Nishimura; Hideo Kaneko
Journal:  Allergy Asthma Immunol Res       Date:  2009-12-30       Impact factor: 5.764

4.  A regulatory polymorphism in interferon-gamma receptor 1 promoter is associated with the susceptibility to chronic hepatitis B virus infection.

Authors:  Jie Zhou; Ding-Qiang Chen; Vincent K M Poon; Yong Zeng; Fai Ng; Liwei Lu; Jian-Dong Huang; Kwok-Yung Yuen; Bo-Jian Zheng
Journal:  Immunogenetics       Date:  2009-06-02       Impact factor: 2.846

5.  IFNGR1 single nucleotide polymorphisms in rheumatoid arthritis.

Authors:  Stefan Mattyasovszky; Alla Skapenko; Joachim R Kalden; Peter E Lipsky; Hendrik Schulze-Koops
Journal:  Arthritis Res Ther       Date:  2006-03-23       Impact factor: 5.156

6.  Targeted deep sequencing identifies rare loss-of-function variants in IFNGR1 for risk of atopic dermatitis complicated by eczema herpeticum.

Authors:  Lianghua Bin; Kathleen C Barnes; Li Gao; Nicholas M Rafaels; Lili Huang; Joseph Potee; Ingo Ruczinski; Terri H Beaty; Amy S Paller; Lynda C Schneider; Rich Gallo; Jon M Hanifin; Lisa A Beck; Raif S Geha; Rasika A Mathias; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2015-09-03       Impact factor: 10.793

7.  Inborn Errors of Immunity Associated With Type 2 Inflammation in the USIDNET Registry.

Authors:  Kelsey L Smith; Darlene Dai; Bhavi P Modi; Rahnuma Sara; Elizabeth Garabedian; Rebecca A Marsh; Jennifer Puck; Elizabeth Secord; Kathleen E Sullivan; Stuart E Turvey; Catherine M Biggs
Journal:  Front Immunol       Date:  2022-02-22       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.